Literature DB >> 23247035

Primary extraosseous Ewing sarcoma of the orbit.

Jorge L Alio1, Marco Sales-Sanz, Maria A Vaz, Constanza Barrancos, Maria E Reguero, Jorge Diamantopoulus, Pedro Poveda.   

Abstract

A 40-year-old man presented with painless, progressive vision loss and mild proptosis of the OD. CT revealed a right intraconal mass with slight penetration of the optic canal not contiguous with any bony structure. Incisional biopsy through a transfrontal orbitotomy revealed a diffuse growth of homogeneous, small, round cells. Immunohistochemical stains were positive for vimentin and MIC2 (CD99), and the translocation at EWS gene (22q12) was detected. Metastatic workup and a full-body bone scan were negative, confirming primary orbital extraosseous Ewing sarcoma. The patient received neoadjuvant chemotherapy and an orbital exenteration with preservation of eyelids and conjunctiva. He also received adjuvant chemotherapy and local radiotherapy, and he has remained disease-free for almost 3 years.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23247035     DOI: 10.1097/IOP.0b013e3182771549

Source DB:  PubMed          Journal:  Ophthalmic Plast Reconstr Surg        ISSN: 0740-9303            Impact factor:   1.746


  3 in total

1.  Exenteration and Custom Implant Brachytherapy as a Treatment for Recurrent Primary Extraskeletal Orbital Ewing Sarcoma.

Authors:  Michael A Klufas; Suzanne L Wolden; George C Bohle; Leonard H Wexler; David H Abramson
Journal:  Ophthalmic Plast Reconstr Surg       Date:  2015 Jul-Aug       Impact factor: 1.746

Review 2.  An update on mesenchymal tumours of the orbit with an emphasis on the value of molecular/cytogenetic testing.

Authors:  F Roberts; E M MacDuff
Journal:  Saudi J Ophthalmol       Date:  2018-03-06

3.  Peripheral primitive neuroendocrine tumor of the chest wall-A case report with pathological correlation.

Authors:  Jidi Gao; Erika Chow; Aishatu Aloma; Payal Gupta
Journal:  Radiol Case Rep       Date:  2018-02-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.